Vimarsana
Biggest News Aggregation in the World

Sumatriptan Injection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sumatriptan Injection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sumatriptan Injection Today - Breaking & Trending Today

Analyzing IRadimed (NASDAQ:IRMD) and Antares Pharma (NASDAQ:ATRS) - Vimarsana News

Analyzing IRadimed (NASDAQ:IRMD) and Antares Pharma (NASDAQ:ATRS)

Antares Pharma (NASDAQ:ATRS – Get Rating) and IRadimed (NASDAQ:IRMD – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Valuation & Earnings This table compares Antares Pharma and IRadimed’s […]

Head to Head Survey: InfuSystem (NYSE:INFU) & Antares Pharma (NASDAQ:ATRS) - Vimarsana News

Head to Head Survey: InfuSystem (NYSE:INFU) & Antares Pharma (NASDAQ:ATRS)

InfuSystem (NYSE:INFU – Get Rating) and Antares Pharma (NASDAQ:ATRS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Valuation & Earnings This table compares InfuSystem and Antares Pharma’s […]

Analyzing Antares Pharma (NASDAQ:ATRS) and Dynatronics (NASDAQ:DYNT) - Vimarsana News

Analyzing Antares Pharma (NASDAQ:ATRS) and Dynatronics (NASDAQ:DYNT)

Antares Pharma (NASDAQ:ATRS – Get Rating) and Dynatronics (NASDAQ:DYNT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations. Profitability This table compares Antares Pharma and Dynatronics’ net margins, […]

Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares Pharma, Inc. - Vimarsana News

Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares Pharma, Inc.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Antares Pharma Announces Divestiture of Otrexup® - Vimarsana News

Antares Pharma Announces Divestiture of Otrexup®

EWING, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced...